ASX:IBX Imagion Biosystems (IBX) Stock Price, News & Analysis → “Dollar Will Be Worth NOTHING” -Musk (From Crypto 101 Media) (Ad) Free IBX Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume10.77 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Imagion Biosystems alerts: Email Address Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. About Imagion BiosystemsImagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It has activities in nanotechnology; biotechnology; cancer diagnostics; and superparamagnetic relaxometry. The company develops MagSense, which is in Phase I clinical trials for the treatment of HER2 breast cancers; and PrecisionMRX, an iron oxide nanoparticle to detect cancer. Imagion Biosystems Limited has a collaborative research program with Patrys Limited to use the MagSense nanoparticles for enhancing brain tumor imaging and diagnosis. The company was incorporated in 2016 and is based in San Diego, California.Read More Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. IBX Stock News HeadlinesApril 12, 2024 | finance.yahoo.comImagion Biosystems Limited (IBXXF)March 6, 2024 | morningstar.comImagion Biosystems Ltd IBXJanuary 30, 2024 | wsj.comT2 Biosystems Inc.December 13, 2023 | finance.yahoo.comImagion Announces Positive Results from IBI10103 Phase I Study Demonstrating Safety and Clinical Feasibility of Molecular MRI with MagSense® HER2 Imaging AgentNovember 27, 2023 | lse.co.ukXtrack Ibx Eur Corpe Yld Plus Ucits Etf Share Price (XDEP.MI)November 18, 2023 | lse.co.ukLyxor Ibx $ Liquid Emergi Sov Ucits Etf Share Price (EMKTB.MI)August 6, 2023 | fool.comT2 Biosystems (NASDAQ: TTOO)June 21, 2023 | msn.comCLOSING BELL: Investors respond to the government’s Critical Minerals Strategy by selling everything in sightJune 20, 2023 | msn.comTop 10 at 10: Microcap biotech Imagion up 33pc after achieving enrolment target for Phase 1 trialJune 18, 2023 | finance.yahoo.comIBX.AX - Imagion Biosystems LimitedMay 31, 2023 | finance.yahoo.comManhattan Scientifics Celebrates Imagion Biosystems' Milestones in Early Cancer Detection TechnologyApril 1, 2023 | finance.yahoo.comStilla Technologies and Atila BioSystems to Co-Develop High-Plex Digital PCR Kits for OncologyMarch 26, 2023 | seekingalpha.comT2 Biosystems affirms plans to add Candida Auris fungus detection to test panelFebruary 7, 2023 | finance.yahoo.comHere's Why We're A Bit Worried About Imagion Biosystems' (ASX:IBX) Cash Burn SituationFebruary 6, 2023 | msn.comCLOSING BELL: Not even the promise of top-shelf psychedelics could lift the market’s moodDecember 7, 2022 | msn.comASX Health Stocks: Imagion jumps 20pc after delivering positive Phase 1 resultsAugust 26, 2022 | nz.finance.yahoo.comWe're Keeping An Eye On Imagion Biosystems' (ASX:IBX) Cash Burn RateJuly 19, 2022 | afr.comImagion Biosystems LimitedMarch 17, 2022 | finance.yahoo.comManhattan Scientifics Announces Early Results from Cancer CompanyMarch 17, 2022 | proactiveinvestors.com.auASX closes higher as unemployment falls to record lows and short sellers bet on oilMarch 17, 2022 | msn.comThe Imagion Biosystems (ASX:IBX) share price just exploded by 60%. Here’s whyFebruary 3, 2022 | finance.yahoo.comImagion Biosystems' (ASX:IBX) investors will be pleased with their solid 125% return over the last three yearsNovember 11, 2021 | fool.com.auThe Imagion Biosystems (ASX:IBX) share price leapt 40% in 2 days this week. What’s happening?November 5, 2021 | finance.yahoo.comWe're Hopeful That Imagion Biosystems (ASX:IBX) Will Use Its Cash WiselyOctober 28, 2021 | msn.comImagion Biosystems (ASX:IBX) share price soars 13% on quarterly updateSee More Headlines Receive IBX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Imagion Biosystems and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:IBX CUSIPN/A CIKN/A Webwww.imagionbiosystems.com Phone855-564-5264FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.43) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,070,000.00 Net Margins-252.26% Pretax MarginN/A Return on Equity-350.37% Return on Assets-99.05% Debt Debt-to-Equity Ratio98.44 Current Ratio0.11 Quick Ratio4.04 Sales & Book Value Annual Sales$5.18 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow3.00 Book ValueA($0.14) per share Price / BookN/AMiscellaneous Outstanding Shares32,650,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.88 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesMr. Robert Romeo Proulx (Age 66)Executive Chairman Comp: $512.03kMr. Geoff Hollis AGIABComm, CA, CFO & Company SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYAustralian Clinical LabsASX:ACLBARD1 Life SciencesASX:BD1BCAL DiagnosticsASX:BDXbioAffinity TechnologiesNASDAQ:BIAFWView All CompetitorsInsidersIsaac BrightSold 187,500 sharesTotal: $64,687.50 ($0.35/share) IBX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Imagion Biosystems own? Based on aggregate information from My MarketBeat watchlists, some companies that other Imagion Biosystems investors own include Arcadia Biosciences (RKDA), Schroders (PYX), Paradigm Biopharmaceuticals (PAR), Alibaba Group (BABA) and Amani Gold (ANL). This page (ASX:IBX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsThe 1,000X Crypto PlaybookTrue Market InsidersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityThe #1 Crypto for AIWeiss RatingsWhy Is Gold On a MASSIVE rally? Huge AlertsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imagion Biosystems Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
